Acceptability and Feasibility of a Randomized Clinical Trial of Oral Naltrexone vs. Placebo for Women Living with HIV Infection: Study Design Challenges and Pilot Study Results.

Authors

Robert L. Cook
Kathleen M. Weber
Dao Mai
Kathleen A. Thoma, George Washington UniversityFollow
Xingdi Hu
Babette Brumback
Manju Karki
Kendall Bryant
Mobeen Rathore
Mary Young
Mardge Cohen

Document Type

Journal Article

Study Type

Randomized Controlled Trial

Publication Date

9-2017

Journal

Contemporary Clinical Trials

Volume

60

Inclusive Pages

72-77

DOI

10.1016/j.cct.2017.06.012

Keywords

naltrexone; women living with HIV and alcohol abuse

APA Citation

Cook, R. L., Weber, K. M., Mai, D., Thoma, K. A., Hu, X., Brumback, B., Karki, M., Bryant, K., Rathore, M., Young, M., & Cohen, M. (2017). Acceptability and Feasibility of a Randomized Clinical Trial of Oral Naltrexone vs. Placebo for Women Living with HIV Infection: Study Design Challenges and Pilot Study Results.. Contemporary Clinical Trials, 60 (). http://dx.doi.org/10.1016/j.cct.2017.06.012

Peer Reviewed

1